Partner With Us
As the only event exclusively dedicated to glioblastoma drug development, this conference offers an unparalleled opportunity for industry leaders to engage with top experts from every corner of the GBM space. Attendees include key figures from large pharma, biotech, neuro-oncology, clinical practice, investment, and academia—all focused on driving progress in glioblastoma treatment. With a growing demand for innovative models, diagnostics, and delivery technologies, this forum is the ideal setting to identify market gaps that your products and services can address.
Recent breakthroughs, such as the positive results for IDH-2 mutant low grade glioma therapies, have sparked renewed optimism within the GBM research community. As the field approaches a critical turning point, there is momentum for a major shift in how glioblastoma and other CNS tumors are treated.
This event provides a unique chance to position your company at the forefront of these developments, aligning with the most cutting-edge research and development in neuro-oncology. It's the perfect moment to establish valuable partnerships and showcase your role in advancing transformative solutions for one of the most challenging areas of oncology. Join us and be part of a movement that's changing the future of GBM treatment.
Why Partner:
Providing unparalleled opportunities for high-level networking with influential decision-makers and pioneers driving the future of GBM research and treatment innovation, this event stands as the exclusive forum entirely dedicated to glioblastoma, making it the premier gathering for experts in the field. |
Position your brand in front of key neuro-oncology professionals who are actively seeking innovative services, unlocking new business prospects and fostering valuable connections with industry leaders. |
With the field facing unique hurdles and an urgent demand for solutions, the market is open to novel approaches, and this event offers a prime stage to demonstrate how your preclinical models, delivery solutions & diagnostic technology can provide essential insights, support drug development, and improve treatment outcomes, positioning your solutions as key to advancing the field. |